Evaluation of Patients Treated With Natalizumab Finds No New Cases of Progressive Multifocal LeukoencephalopathyWednesday, Mar 1, 2006
An independent clinical and laboratory study of more than 3000 people treated with the drug natalizumab (Tysabri®) for multiple
sclerosis (MS), Crohn’s disease, and rheumatoid arthritis has found no evidence of new cases of the often-fatal disorder called
progressive multifocal leukoencephalopathy (PML). The laboratory component of the study was coordinated by the National Institute
of Neurological Disorders and Stroke (NINDS) at the National Institutes of Health (NIH), working in conjunction with the NIH
Clinical Center.
Evaluation of Patients Treated With Natalizumab Finds No New Cases of Progressive Multifocal LeukoencephalopathyWednesday, Mar 1, 2006
An independent clinical and laboratory study of more than 3000 people treated with the drug natalizumab (Tysabri®) for multiple
sclerosis (MS), Crohn’s disease, and rheumatoid arthritis has found no evidence of new cases of the often-fatal disorder called
progressive multifocal leukoencephalopathy (PML). The laboratory component of the study was coordinated by the National Institute
of Neurological Disorders and Stroke (NINDS) at the National Institutes of Health (NIH), working in conjunction with the NIH
Clinical Center.
Serotonin Receptor Lets JC Virus Enter Brain CellsFriday, Jan 14, 2005
Researchers funded in part by the National Institute of Neurological Disorders and Stroke (NINDS) have identified the cellular
receptor for the JC virus, which causes the fatal neurological disease progressive multifocal leukoencephalopathy (PML).
Generic medicines currently available may be useful in preventing the infection.
Serotonin Receptor Lets JC Virus Enter Brain CellsFriday, Jan 14, 2005
Researchers funded in part by the National Institute of Neurological Disorders and Stroke (NINDS) have identified the cellular
receptor for the JC virus, which causes the fatal neurological disease progressive multifocal leukoencephalopathy (PML).
Generic medicines currently available may be useful in preventing the infection.
Study Detects Brain Virus in HIV-Positive PatientsTuesday, May 5, 1992
Scientists at the National Institute of Neurological Disorders and Stroke (NINDS) have identified a potentially fatal virus
in the bloodstream in half of a small group of HIV-positive patients without neurological symptoms, they announced today at
the annual meeting of the American Academy of Neurology in San Diego.
Study Detects Brain Virus in HIV-Positive PatientsTuesday, May 5, 1992
Scientists at the National Institute of Neurological Disorders and Stroke (NINDS) have identified a potentially fatal virus
in the bloodstream in half of a small group of HIV-positive patients without neurological symptoms, they announced today at
the annual meeting of the American Academy of Neurology in San Diego.